06929 ORBUSNEICH
- 4.750
- +0.240+5.32%
ORBUSNEICH News
Earnings Not Telling The Story For OrbusNeich Medical Group Holdings Limited (HKG:6929) After Shares Rise 28%
Those holding OrbusNeich Medical Group Holdings Limited (HKG:6929) shares would be relieved that the share price has rebounded 28% in the last thirty days, but it needs to keep going to repair the rec
We Think That There Are Issues Underlying OrbusNeich Medical Group Holdings' (HKG:6929) Earnings
Despite posting some strong earnings, the market for OrbusNeich Medical Group Holdings Limited's (HKG:6929) stock hasn't moved much. We did some digging, and we found some concerning factors in the d
ORBUSNEICH: ANNUAL REPORT 2023
Some Confidence Is Lacking In OrbusNeich Medical Group Holdings Limited (HKG:6929) As Shares Slide 28%
To the annoyance of some shareholders, OrbusNeich Medical Group Holdings Limited (HKG:6929) shares are down a considerable 28% in the last month, which continues a horrid run for the company. The r
Revenue and profit reached a record high and achieved the first dividend, and Yeju Healthcare (6929.HK) became a new benchmark for the industry
The Hong Kong stock market has been sluggish recently. As listed companies announce their results one after another, investors might as well use low valuations to find high-quality companies. On March 7, a medical device company that has been on the market for more than a year announced its results. Not only did its revenue grow by double digits for the third year in a row, but it also doubled its profits. The company gave back to shareholders with excellent performance and announced dividends for the first time. It can be seen that management has confidence in the company's future development potential. Furthermore, the company completed three acquisitions in just over a year after listing, increasing the size of the enterprise and fully demonstrating the execution ability of management. This company went public in December 2022 and is mainly engaged in coronary and peripheral interventional medical devices
OrbusNeich Medical Group Holdings Limited Just Recorded A 21% EPS Beat: Here's What Analysts Are Forecasting Next
Last week, you might have seen that OrbusNeich Medical Group Holdings Limited (HKG:6929) released its annual result to the market. The early response was not positive, with shares down 9.5% to HK$3.98
ORBUSNEICH To Go Ex-Dividend On June 11th, 2024 With 0.1 HKD Dividend Per Share
March 8th - $ORBUSNEICH(06929.HK)$ is trading ex-dividend on June 11th, 2024. Shareholders of record on June 12th, 2024 will receive 0.1 HKD dividend per share on June 28th, 2024. The ex-dividend
Changes in Hong Kong stocks | Yeju Healthcare (06929) rose more than 6%, annual net profit increased 143.8% year-on-year to US$45.73 million
Yeju Healthcare (06929) rose more than 6%. As of press release, it rose 6.2% to HK$4.11, with a turnover of HK$1.672,100.
Yeju Medical will pay a final dividend of HK$0.1 per share on June 28
Yeju Healthcare (06929) announced that it will pay a final dividend of HK$0.1 per share for the year ended 31 December 2023 on June 28, 2024.
Selected GLONGHUI Announcements (Hong Kong Stock) | Site B Releases 2023 Q4 and Annual Financial Report: Gross Margin Increased for Six Consecutive Quarters, Achieving Positive Operating Cash Flow Throughout the Year
[Today's Focus] Station B released its financial report for Q4 and the full year of 2023: gross margin increased for six consecutive quarters, achieving positive operating cash flow for the whole year on March 7, Beijing time (March 7, EST). Bilibili (NASDAQ: BILI, HKEX: 9626; hereinafter referred to as “Station B”) announced unaudited financial reports for the fourth quarter and full year ending December 31, 2023. Financial reports show that in 2023, Station B's total revenue for the full year reached RMB 22.53 billion, of which total revenue for the fourth quarter reached RMB 6.35 billion. In 2023, B stands to ensure high-quality user growth
OrbusNeich Medical Group's Profit Up 144% in 2023
OrbusNeich Medical Group Holdings (HKG:6929) recorded a 143.8% rise in attributable profit for the year 2023 to around $45.1 million from $18.5 million in 2022, a Thursday filing on the Hong Kong bour
Yeju Healthcare (06929) will pay a final dividend of HK$0.1 per share on June 28
Yeju Medical (06929) issued an announcement that it will be distributed on June 28, 2024 until December 3, 2023...
Yeju Healthcare (06929) announced annual results. Profit attributable to shareholders of US$45.73 million increased 143.8% year-on-year
Yeju Healthcare (06929) announced its annual results for the year ended December 31, 2023. The group achieved revenue of US$154 million during the period, an increase of 12.5% over the previous year; profit attributable to shareholders of US$45.73 million, an increase of 143.8% over the previous year; basic profit per share of 5.45 US cents; and the proposed dividend of HK10 cents per share.
ORBUSNEICH: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 AND CHANGE IN USE OF PROCEEDS
Yeju Healthcare (06929): Removing the Hong Kong Stock Connect List and Going Overseas, It's Hard to Eat Fresh Every Day
Yeju Healthcare (06929) ushered in the “darkest hour”.
Returns On Capital At OrbusNeich Medical Group Holdings (HKG:6929) Have Stalled
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Firstly, we'll want to see a proven return on capital employ
Yeju Healthcare (06929.HK) plans to hold a board meeting on March 7 to approve the annual results
Gelonghui, Feb. 23, 丨 Yeju Healthcare (06929.HK) issued an announcement. The board of directors is pleased to hold a board meeting on March 7, 2024 (Thursday) to consider and approve the annual results of the company and its subsidiaries for the year ended 31 December 2023 and their publication, consider proposals to pay a final dividend (if any), and handle any other matters.
ORBUSNEICH: DATE OF BOARD MEETING
Yeju Healthcare (06929) fell 2.40% and now reports 4.880 yuan, a 52-week low
As of 16:08, Yeju Healthcare (06929) is down 2.40% from yesterday's closing price and now reports a 52-week low of $4.880; the trading volume is 25,500 shares, with a turnover of HK$125,000.
OrbusNeich Expects More Than Doubling of 2023 Profit
OrbusNeich Medical Group Holdings (HKG:6929) expects its attributable profit to more than double year over year in 2023, a Tuesday filing said. The surge in profit is attributable to higher sales from
Analysis
Price Target
No Data
